Human Genome Research in Massachusetts
Human Genome Research (93.172) awarded $350 million to recipients in Massachusetts in 162 grants from fiscal 2021 to 2025, 16% of the program's national total. The Broad Institute, Inc received the most, $119 million.
- Awarded in Massachusetts$350 million
- Awards162
- Share of the program16%
- Rank among states2nd of 45
- National total$2.2 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 73 | $63.1 million |
| FY 2022 | 74 | $63.6 million |
| FY 2023 | 83 | $68.9 million |
| FY 2024 | 96 | $75.0 million |
| FY 2025 | 84 | $79.8 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Broad Institute, Inc | Nonprofits | 22 | $119 million |
| President and Fellows of Harvard College | Colleges and universities | 17 | $35.3 million |
| The General Hospital Corporation | Nonprofits | 18 | $31.0 million |
| Dana-Farber Cancer Institute, Inc. | Nonprofits | 13 | $29.9 million |
| University of Massachusetts Medical School | Colleges and universities | 9 | $22.5 million |
| Brigham & Womens Hospital Inc | Nonprofits | 16 | $20.6 million |
| President and Fellows of Harvard College | Colleges and universities | 7 | $17.2 million |
| The Children's Hospital Corporation | Nonprofits | 12 | $16.6 million |
| Northeastern University | Colleges and universities | 6 | $12.3 million |
| Whitehead Institute for Biomedical Research | Nonprofits | 3 | $12.2 million |
Open opportunities under this program
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
See all 64 on the program page
Questions people ask
How much Human Genome Research money goes to Massachusetts?
$350 million from fiscal 2021 to 2025, across 162 awards. Massachusetts ranks 2nd of 45 states and territories for this program.
Who receives Human Genome Research money in Massachusetts?
The largest recipient is The Broad Institute, Inc, with $119 million in 22 awards. Next are President and Fellows of Harvard College and The General Hospital Corporation.
Can organizations in Massachusetts apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Human Genome Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research